V-Bio Ventures has announced the first closing of its V-Bio Fund 2 at €78m. The fund is focussed on...
Up To Date
Latest News
The transatlantic Abingworth Bioventures 8 Fund has been closed at $464m to invest in US, UK and European life...
As rapidly spreading mutants of SARS-CoV-2 are emerging, two Tuebingen-based vaccine developers will develop...
German CDMO Rentschler Biopharma is expanding cCMP production of CureVac NV’s RNA-based COVID-19 vaccine...
Enthera Pharmaceuticals extends its €28m Series A financing from last July to a total of €35m as Roche Venture...
A US subsidiary of Hamburg-based Evotec SE has won a contract from the US government to produce antibodies...